Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
XRP44X
Cat. No.:
OB0225LY-0038
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
XRP44X is a small molecule compound that targets and inhibits the JNK signaling pathway.
Synonym:
XRP-44-X; XRP 44X; XRP-44X; XRP 44 X; 729605-21-4; (4-(3-Chlorophenyl)piperazin-1-yl)(3-methyl-1-phenyl-1H-pyrazol-5-yl)methanone; [4-(3-Chlorophenyl)piperazin-1-yl]-(5-methyl-2-phenylpyrazol-3-yl)methanone; 1-(3-Chlorophenyl)-4-((3-methyl-1-phenyl-1H-pyrazol-5-yl)carbonyl)piperazine
CAS No.:
729605-21-4
Compound CID:
10339779
Formula:
C21H21ClN4O
Formula Weight:
380.87
Specification
Relative Density:
1.27 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
XRP44X is used to study cellular stress responses and apoptotic processes in disease models, particularly in relation to inflammation, neurodegenerative diseases, obesity and cancer.
Library Information
Targets:
Ras
Pathways:
MAPK; GPCR/G protein
Plate Number:
AOCL-1
Plate Location:
d10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
36.67 mg/ml; 96.27 mM
